We’re into the flu season again. The U.S. Centers for
Disease Control and Prevention says “36,000 Americans
die of flu-related illness every year” and 90 percent
of flu-related deaths occur among people 65 years and
older. This means one in 1,000 people in that age
bracket is likely to die a flu-related death. The Oct.
25 washingtonpost.com put in context: “The chance of a
flu-related death is slightly lower than the chance of
dying from a fall or other accident.”
On Nov. 1, President George W. Bush asked Congress for
$7.1 billion to deal with a future flu epidemic that
may infect 200 million Americans and kill 200,000.
In the Oct. 31 Newsweek, in “The Fight Against the
Flu,” it was reported, “There is no question that the
administration is taking the threat of avian flu
seriously” and “epidemiologists agree that a flu
pandemic is inevitable sooner or later.”
The head of pandemic-flu preparedness for the World
Health Organization, Dr. Margaret Chan, warned that
historically, “no human intervention” has been able to
stop a pandemic once it starts, but today we can see a
“pandemic unfold before our eyes,” which gives us a
minimal window of “20 to 21 days” to control a local
breakout before it expands exponentially.
Newsweek’s Fareed Zakaria wrote in “A Threat Worse
Than Terror” that a crude nuclear device would kill
hundreds of thousands, but a flu pandemic “could
easily kill millions.” Senior fellow for global health
at the Council on Foreign Relations Laurie Garrett,
“The Next Epidemic?” author, told ABC News, “Short of
thermonuclear war, I have a hard time imagining
anything in my lifetime that would be as horrible.”
Worth reading are questions and answers on the bird
flu in the Oct. 14 CNN.com’s “Bird flu: What you need
to know.” Avian flu, an infectious disease of birds
caused by type A strains of the flu virus, was
identified in Italy more than 100 years ago. It
normally infects no other species than birds and pigs.
Genetic studies reveal that the virus has very rarely
jumped from birds to humans, but in 1997 in Hong Kong,
18 people were infected with the H5N1 strain, one of
15 avian flu virus subtypes. Six died. Symptoms
included fever, sore throat, cough and, in fatal
cases, severe respiratory distress secondary to viral
pneumonia.
In the last few years, the H5N1 strain of avian flu
has pillaged Asia’s domesticated poultry and spread to
migratory birds that carried the virus from East Asia
through Kazakhstan, Russia, Turkey, southeastern
Europe and now East Africa.
Zakaria pointed out that the bird flu problem started
in China’s Guangdong Province. China’s development and
urbanization have reduced the country’s forests and
wetlands, he said, forcing migratory birds to gather
closer together and nearer to human habitation.
Although H5N1 does not — yet — transmit from human
to human, Dr. Henry I. Miller, a physician and fellow
at the Hoover Institution, warned in the Oct. 17 Wall
Street Journal’s “Reasons to Be Fearful,” that the
“flu virus mutates readily, and virologists expect
that sooner or later it will acquire the ability to
spread from person to person.” When the virus becomes
“highly transmissible” among humans, a worldwide
outbreak will become a reality. He said the mortality
rate of those infected with H5N1 is about 50 percent;
the “garden-variety annual flu” kills less than one
percent.
Of the 122 human cases of avian flu since December
2003, 62 have died.
The Nov. 2 Washington Post listed a Web site,
www.pandemicflu.gov, that suggests what every American
can do in the event of an outbreak. Public support for
strategies to limit contagion will be essential:
frequent hand-washing, travel restrictions during an
outbreak, self-imposed home quarantines of the ill,
and stockpiling of food and other essential items.
At present, Tamiflu is the only existing drug to
prevent the flu, and Relenza treats the flu. Tamiflu
is good as long as one takes the drug. But the H5N1
that infected a patient in Vietnam seems to be
resistant to Tamiflu.
While vaccine research focuses today on the H5N1 avian
flu virus, Zakaria called for a “massive biomedical
project” to tackle “all strains” of the flu, a tall
order, he confessed, but “it could be achieved.”
A. Gaffar Peang-Meth, Ph.D., is retired from the
University of Guam, where he taught political science
for 13 years. Write him at peangmeth@yahoo.com.
Originally published November 9, 2005